WO1998029091A1 - Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur - Google Patents
Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur Download PDFInfo
- Publication number
- WO1998029091A1 WO1998029091A1 PCT/FR1997/002461 FR9702461W WO9829091A1 WO 1998029091 A1 WO1998029091 A1 WO 1998029091A1 FR 9702461 W FR9702461 W FR 9702461W WO 9829091 A1 WO9829091 A1 WO 9829091A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymer
- composition
- chosen
- dispersion
- use according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Definitions
- the present invention relates to an anti-wrinkle composition containing a polymer system comprising at least one polymer of natural origin, and to the use of this polymer system as a tightening agent in a cosmetic composition or for the manufacture of a dermatological composition, intended in particular to the treatment, reduction, erasure and / or smoothing of wrinkles and fine lines of human skin.
- the main clinical signs of skin aging include the appearance of fine lines and deep wrinkles, which increase with age.
- the object of the present invention is precisely the use of a particular polymer system making it possible to obtain this effect immediately.
- the Applicant has discovered that certain polymers of natural origin have specific physical characteristics and constitute particularly effective tightening agents.
- the term “tightening agent” is understood to mean compounds capable of having a tightening effect, that is to say that can tighten the skin and, by this tensioning effect, smooth the skin and cause wrinkles to diminish or even disappear there immediately. and fine lines.
- the polymers used according to the invention must have well-defined characteristics, and in particular have a molecular weight greater than 670,000 daltons, which means that at least one fraction of the polymer has a molecular weight greater than 670,000 daltons .
- the polymer systems used according to the invention must be able to form a film permeable to water vapor, have a Young's modulus ranging from 10 8 to 9.10 9 N / m 2 and produce at a concentration of 7 % in water, a retraction of the isolated stratum corneum of more than 1.5% at 30 ° C under a relative humidity of 40%.
- the subject of the present invention is the use of at least one dispersion of a polymer system containing at least one polymer of natural origin having a molecular weight greater than 670,000 daltons, the said polymer system being capable of forming a vapor permeable film, having a Young's modulus ranging from 10 8 to 9.10 9 N / m 2 and producing at a concentration of 7% in water, a retraction of the isolated stratum corneum of more than 1.5% at 30 ° C under a relative humidity of 40%, in a cosmetic composition to reduce and / or erase wrinkles and / or fine lines of the skin by tightening effect.
- the present invention also relates to the use of at least one dispersion of a polymer system containing at least one polymer of natural origin having a molecular weight greater than 670,000 daltons, the said polymer system being capable of forming a film.
- vapor permeable having a Young's modulus ranging from 10 8 to 9.10 9 N / m 2 and producing, at a concentration of 7% in water, a retraction of isolated stratum corneum of more than 1, 5% C to 30 C under a relative humidity of 40%, as a tightening agent in a cosmetic composition with a view to reducing and / or erasing wrinkles and / or fine lines from the skin.
- the subject of the invention is also the use of at least one dispersion of a polymer system containing at least one polymer of natural origin having a molecular weight greater than 670,000 daltons, the said polymer system being capable of forming a film.
- vapor permeable having a Young's modulus ranging from 10 8 to 9.10 9 N / m 2 and producing at a concentration of 7% in water, a retraction of the isolated stratum corneum of more than 1.5% to 30 ° C under a relative humidity of 40%, for the manufacture of a dermatological composition intended to erase wrinkles and / or fine lines from the skin by tightening effect.
- the invention also relates to a method of cosmetic treatment of wrinkled skin consisting in applying to the wrinkle at least one dispersion of a polymer system containing at least one polymer of natural origin having a molecular weight greater than 670,000 daltons , the said polymer system being capable of forming a vapor-permeable film, having a Young's modulus ranging from 10 8 to 9.10 9 N / m 2 and producing, at a concentration of 7% in water, a retraction of the stratum corneum isolated by more than 1.5% at 30 ° C at a relative humidity of 40%, in an amount effective to reduce wrinkles by tightening effect.
- the invention also relates to an anti-wrinkle composition, characterized in that it contains, in a physiologically acceptable medium to the skin for several hours, at least one dispersion of a polymer system containing at least one polymer 'naturally occurring having a molecular weight greater than 670,000 daltons, the said polymer system being capable of forming a vapor permeable film, having a Young's modulus ranging from 10 8 to 9.10 9 N / m 2 and producing at a concentration of 7% in water, a retraction of the isolated stratum corneum of more than 1.5% at 30 ° C at 40% relative humidity.
- the polymer system used according to the present invention has the property of blurring immediately after application, wrinkles and fine lines on the surface of the skin.
- the composition of the invention is more particularly suitable for application to the face and the neck, in particular the Vietnameselleté.
- polymeric system is meant either a polymer alone or a polymer associated with at least one other polymer or a polymer associated with at least one plasticizing agent so as to obtain the desired mechanical characteristics.
- a film By “capable of forming a film”, is meant a polymeric system making it possible to form a film: when spread on glass, the polymeric system must dry without individualizing like a lacquer film.
- water permeable By water permeable is meant a porous film of water vapor.
- the permeability of the film is demonstrated by measuring the PIE (insensible water loss) of the defatted stratum corneum treated by the polymer system.
- the PIE insensible water loss
- the film is porous to water vapor, the PIE is not modified by the film.
- the measurement of the PIE is carried out in a conventional manner using an evaporometer (Servomed) which quantitatively determines the evaporation of water, that is to say a transport of water by diffusion, from '' a sample of stratum corneum sealing a cylindrical capsule containing water, the whole being placed in a chamber at controlled temperature and relative humidity.
- Sensors make it possible to measure the partial pressure of water vapor at two points located at different distances from the sample. We thus determines the partial pressure gradient of water vapor between the two points, and therefore the rate of evaporation in accordance with Fick's law.
- the polymer system used according to the invention has a Young's modulus ranging from 10 8 to 9.10 9 N / m 2 , determined by instrumented indentation methods (micro- or nano-indentation; ASTM standard E384-89), which corresponds to a modulus of elasticity at least 10 to 100 times greater than that of the stratum corneum.
- the use of a polymer system having such a Young's modulus makes it possible to obtain both immediate and persistent efficiency and good comfort in the tensor effect, that is to say without excessive tightness.
- the polymer system used according to the invention produces, at a concentration of 7% in water, a retraction of the isolated stratum corneum by more than 1.5% at 30 ° C under a relative humidity of 40%. This retraction is measured with a dermometer.
- Patent application WO96 / 19180 describes compositions for firming the skin comprising a film-forming agent containing at least one vegetable polysaccharide and hydrolysed casein as tensing active agents.
- the natural polymers described in this patent application do not meet the characteristics of the polymers according to the present invention and they do not make it possible to obtain satisfactory stratum corneum retraction.
- US Pat. No. 3,471,624 describes compositions intended for skin care, in particular for smoothing wrinkles, these compositions comprising methyl cellulose as a stabilizer. This document in no way discloses the use of cellulose derivatives as tensioning agents.
- the polymers according to the invention make it possible to obtain a tightening effect for more than three hours effectively, this effect being very well tolerated by the user (comfort and not tightness).
- polymer of natural origin means polymers of plant origin, polymers derived from skin appendages and latexes of natural origin. These polymers are preferably hydrophilic.
- proteins and protein hydrolysates and more particularly extracts of cereals, legumes and oilseeds, such as extracts of corn, rye, wheat, buckwheat, ⁇ sesame, spelled, pea, bean, lentil, soy and lupine.
- extracts of corn, rye, wheat, buckwheat, ⁇ sesame, spelled, pea, bean, lentil, soy and lupine are particularly from a fraction of molecular weight greater than 670,000 daltons.
- suitable proteins there may be mentioned, for example, the soy protein extract sold by the company ISD under the name "Profam 972" and the protein fraction of white lupine.
- chitin and its derivatives in particular chitosan which is a deacetylated derivative of chitin, as well as chitosan derivatives such as hydroxypropylchitosan, the succinylated derivative of chitosan, chitosan lactate, chitosan glutamate. , carboxymethyichifosane succinamide; keratin derivatives such as keratin hydrolysates and sulfonic keratins.
- the polymers of natural origin, optionally modified, constituting latexes can be chosen, for example, from shellac resin, sandara gum, dammars, elemis, copals, cellulose derivatives, and mixtures thereof.
- the plasticizing agent which may be present can be chosen from all the compounds known to those skilled in the art as being capable of fulfilling the desired function.
- This agent can be water-soluble or insoluble in water and can optionally be in the form of an aqueous dispersion.
- plasticizers such as glycols and their derivatives such as diethylene glycol ethyl ether or methyl ether, ethylene glycol ethyl ether or butyl ether, propylene glycol methyl ether or phenyl ether, dipropylene glycol ethyl ether or butyl ether, tripropylene glycol butyl ether or methyl ether; glycerol esters; esters of acids such as citrates, phthalates, adipates, carbonates, tartrates, phosphates, sebacates; oxyethylenated derivatives such as oxyethylenated oils, in particular vegetable oils such as oxyethylenated castor oil and oxyethylenated silicone oils; polymers which are water-soluble or in aqueous dispersion, having a low glass transition temperature, less than 25 ° C., preferably less than 15 °
- the amount of plasticizer is chosen by the skilled person based on his general knowledge, so as to obtain a polymer system leading to a film having the 'desired mechanical properties, while preserving the composition of the cosmetically acceptable properties .
- the polymer system used (polymer (s) or polymer and plasticizer) according to the invention may in particular be present in an amount of active material (MA) ranging from 0.5 to 70%, and better still from 0.5 to 30% of the total weight of the composition.
- composition containing the polymer system used according to the invention may comprise, in addition to the dispersion of polymer of natural origin, an aqueous dispersion of at least one polymer of synthetic origin and in particular a synthetic polymer in the form of a latex. or a pseudolatex.
- Latexes result directly from the synthesis of a polymer by a well-known emulsion polymerization technique.
- the possible neutralization of the latex is such that the polymer remains in the form of a latex and does not dissolve in water.
- Such latexes are used for example in nail varnishes (see EP-A-648485).
- a polymer is prepared and it is then dispersed in water.
- the dispersion in water is self-stabilized by at least partial neutralization of the acid groups carried by the polymer.
- the latex or pseudolatex particles preferably have a size ranging from 10 to 400 nm and preferably from 20 to 350 nm.
- the synthetic polymers of the latexes or pseudolatex can be of the polycondensate type or of the radical type.
- polycondensates there may be mentioned anionic, cationic, nonionic or amphoteric polyurethanes, polyurethanes-acrylics, polyurethanes-polyvinylpyrrolido ⁇ és, polyester-polyurethanes, polyether-polyurethanes, polyureas, and their mixtures.
- the polyurethane can be, for example, a polyurethane, polyurea / urethane or polyurea, aliphatic, cycloaliphatic or aromatic copolymer.
- Polyurethanes can also be obtained from polyesters, branched or not, or from alkyds comprising mobile hydrogens which are modified by reaction with a diisocyanate and a bifunctional organic compound (for example dihydro, diamino or hydroxyamino), comprising in plus either a carboxylic acid or carboxylate group, or a sulfonic acid or sulfonate group, or even a neutralizable tertiary amine group or a quaternary ammonium group. Mention may also be made of polyesters, polyester amides, fatty chain polyesters, polyamides, and epoxy ester resins.
- a diisocyanate for example dihydro, diamino or hydroxyamino
- a bifunctional organic compound for example dihydro, diamino or hydroxyamino
- Mention may also be made of polyesters, polyester amides, fatty chain polyesters, polyamides, and epoxy ester resins.
- the latexes or pseudolatex can also consist of acrylic polymers, acrylic copolymers (in the CTFA name acrylates copolymer) and sulfonated isophthalic acid polymers.
- the latexes or pseudolatex can also be obtained from polymers resulting from the radical polymerization of one or more radical monomers inside and / or partially on the surface, of pre-existing particles of at least one polymer chosen from the group consisting of polyurethanes, polyureas, polyesters, polyesteramides and / or alkyds. These polymers are generally called hybrid polymers.
- polyester dispersions polyurethane and polyether-polyurethane, sold under the names “Sancure 2060” (polyester-polyurethane), “Sancure 2255" (polyester-polyurethane), “Sancure 815" (polyester-polyurethane), “Sancure 878” (polyether-polyurethane) and “Sancure 861” (polyether-polyurethane) by the company Sanncor, under the names "Neorez R974" (polyester-polyurethane), “Neorez R981” (polyester-polyurethane), “Neorez R970” (polyether-polyurethane) by the company HERE, and the dispersion of acrylic copolymer sold under the name "Neocryl XK-90" by the company Zeneca.
- the synthetic polymer dispersion can be present in an amount of active material preferably ranging from 0.5 to 50% of the total weight of the composition, and preferably from 0.5 to 25% of the total weight of the composition, the amount total of the polymer system being that indicated above.
- the composition containing the polymer system is suitable for topical use and therefore contains a physiologically acceptable medium, that is to say compatible with the skin for several hours.
- a physiologically acceptable medium that is to say compatible with the skin for several hours.
- severe hours is meant at least two hours and preferably more than three hours.
- the pH of the composition is close to the pH of the skin, that is to say from approximately 5 to approximately 8, and preferably 5.5 to 6.5.
- composition of the invention can be in all dosage forms normally used for topical application, in particular in the form of an aqueous, hydroalcoholic or oily solution, of an oil-in-water or water-in-oil emulsion or multiple, of an aqueous or oily gel, of a liquid, pasty or solid anhydrous product, of an oil dispersion in an aqueous phase in the presence of spherules, these spherules possibly being polymeric nanoparticles such as nanospheres and nanocapsules or better lipid vesicles of ionic and / or nonionic type.
- This composition can be more or less fluid and have the appearance of a white or colored cream, an ointment, a milk, a lotion, a serum, a paste, a foam. . It can optionally be applied to the skin in the form of an aerosol. It can also be in solid form, and for example in the form of a stick. It can be used as a care product and / or as a skin makeup product.
- composition of the invention more particularly constitutes an anti-wrinkle composition, in particular in the form of a serum.
- the composition of the invention may also contain the adjuvants customary in the cosmetic and dermatological fields, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, perfumes, fillers, filters, pigments, odor absorbers and coloring matter.
- the amounts of these various adjuvants are those conventionally used in the fields under consideration, and for example from 0.01 to 20% of the total weight of the composition.
- These adjuvants depending on their nature, can be introduced into the fatty phase, into the aqueous phase, into the lipid vesicles and / or into the nanoparticles. These adjuvants and their concentrations must be such that they do not modify the desired tensor property of the polymer system.
- the proportion of the fatty phase can range from 5 to 80% by weight, and preferably from 5 to 50% by weight relative to the total weight of the composition.
- the fats, emulsifiers and coemulsions used in the composition in the form of an emulsion are chosen from those conventionally used in the field considered.
- the emulsifier and the coemulsifier are preferably present in the composition in a proportion ranging from 0.3 to 30% by weight, and preferably from 0.5 to 20% by weight relative to the total weight of the composition.
- mineral oils mineral jelly oil
- oils of vegetable origin oils of vegetable origin
- lanolin oils of animal origin
- synthetic oils perhydrosqualene
- silicone oils cyclomethicone
- fluorinated oils perfluoropolyethers
- Fatty alcohols cetyl alcohol
- fatty acids fatty acids
- waxes and gums and in particular silicone gums can also be used as fats.
- emulsifiers and coemulsifiers which can be used in the invention, there may be mentioned, for example, fatty acid esters of polyethylene glycol such as PEG-50 stearate and PEG-40 stearate, and fatty acid esters of polyol such as glyceryl stearate and sorbitan tristearate.
- hydrophilic gelling agents mention may in particular be made of carboxyvinyl polymers (carbomers), acrylic copolymers such as acrylate / alkyl acrylate copolymers, polyacrylamides, polysaccharides, natural gums and clays, and, as lipophilic gelling agents, cite modified clays such as bentones, metal salts of fatty acids, hydrophobic silica and polyethylenes.
- carboxyvinyl polymers carboxyvinyl polymers
- acrylic copolymers such as acrylate / alkyl acrylate copolymers
- polyacrylamides polysaccharides
- natural gums and clays and, as lipophilic gelling agents, cite modified clays such as bentones, metal salts of fatty acids, hydrophobic silica and polyethylenes.
- polyols glycols
- vitamins keratolytic agents and / or desquamating agents
- keratolytic agents and / or desquamating agents salicylic acid and its derivatives, alpha-hydroxy acids, ascorbic acid and its derivatives
- anti-inflammatory agents can be used, soothing agents and mixtures thereof.
- ⁇ -hydroxy acids there may be mentioned in particular glycolic, lactic, malic, tartaric, citric, mandelic acids.
- ⁇ -hydroxy acids mention may be made of salicylic acid and its derivatives, 2-hydroxyalkanoic acids and their derivatives such as hydroxy-2-methyl-3-benzoic acid and hydroxy-2-methoxy acid -3-benzoic.
- retinoids there may be mentioned retinol and its esters (palmitate, acetate, propionate) as well as retinoic acid and its derivatives.
- tensing agents used according to the invention with other compounds known by a person skilled in the art as tensing agents having properties different from those of the agents used according to the invention, in particular a protein or protein hydrolyzate.
- tensing agents having properties different from those of the agents used according to the invention, in particular a protein or protein hydrolyzate.
- milk proteins such as lactalbumin
- vegetable proteins such as soy protein sold under the name Eleseryl by the company LSN or the oat derivative sold under the name " Reductin "by the company Silab
- nucleic acids like DNA nucleic acids like DNA.
- the active agents indicated above can be incorporated into spherules, in particular ionic or non-ionic vesicles and / or nanoparticles (nanocapsules and / or nanospheres), so as to isolate them from each other in the composition.
- compositions according to the invention are given by way of illustration and without limitation.
- the quantities are given there in% by weight.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97953978A EP0912165A1 (fr) | 1997-01-03 | 1997-12-30 | Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur |
AU57701/98A AU5770198A (en) | 1997-01-03 | 1997-12-30 | Cosmetic and/or dermatological composition containing a dispersion of a polymeric system and use of this system as tensor |
JP10529720A JPH11506474A (ja) | 1997-01-03 | 1997-12-30 | ポリマーシステムの分散物を含む化粧用および/または皮膚科学用組成物並びに当該システムのテンショニング剤としての使用 |
US09/142,046 US6001367A (en) | 1997-01-03 | 1997-12-30 | Cosmetic and/or dermatological composition containing a dispersion of a polymeric system and use of this system as tensor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR97/00033 | 1997-01-03 | ||
FR9700033A FR2758083B1 (fr) | 1997-01-03 | 1997-01-03 | Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/348,167 Continuation-In-Part US6413526B1 (en) | 1997-01-03 | 1999-07-07 | Cosmetic and/or dermatological composition comprising a dispersion of a polymer system, and use of this system as a tensioning agent |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998029091A1 true WO1998029091A1 (fr) | 1998-07-09 |
Family
ID=9502374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1997/002461 WO1998029091A1 (fr) | 1997-01-03 | 1997-12-30 | Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur |
Country Status (6)
Country | Link |
---|---|
US (2) | US6001367A (fr) |
EP (1) | EP0912165A1 (fr) |
JP (1) | JPH11506474A (fr) |
AU (1) | AU5770198A (fr) |
FR (1) | FR2758083B1 (fr) |
WO (1) | WO1998029091A1 (fr) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6413526B1 (en) | 1997-01-03 | 2002-07-02 | L'oreal | Cosmetic and/or dermatological composition comprising a dispersion of a polymer system, and use of this system as a tensioning agent |
JP2002539144A (ja) * | 1999-03-12 | 2002-11-19 | バイオテク エイエスエイ | 化粧品調合物 |
EP1352626A1 (fr) * | 2002-04-12 | 2003-10-15 | L'oreal | Composition cosmétique sous forme d'émulsion multiple comprenant un agent tenseur |
FR2846884A1 (fr) * | 2002-11-12 | 2004-05-14 | Oreal | Composition, notamment cosmetique, comprenant un latex tenseur et un polymere amphiphile ionique |
WO2006102220A2 (fr) * | 2005-03-21 | 2006-09-28 | Johnson & Johnson Consumer Companies, Inc. | Compositions pour la peau comprenant des polymeres de mise en tension et utilisations |
WO2006102447A2 (fr) * | 2005-03-21 | 2006-09-28 | Johnson & Johnson Consumer Companies, Inc. | Methodes de traitement d'une atrophie des tissus cutanes et muqueux a l'aide de compositions renfermant des polymeres de tension |
US7115255B2 (en) | 2000-07-21 | 2006-10-03 | L'oreal | Polymer comprising water-soluble units and LCST units, and aqueous composition comprising same |
EP1708677A2 (fr) * | 2004-01-07 | 2006-10-11 | E-L Management Corp. | Composition cosmetique contenant une proteine et un inhibiteur d'enzyme |
FR2885037A1 (fr) * | 2005-05-02 | 2006-11-03 | Oreal | Kit de maquillage des matieres keratiniques et procede de mise en oeuvre |
FR2885038A1 (fr) * | 2005-05-02 | 2006-11-03 | Oreal | Kit de maquillage des matieres keratiniques et procede de mise en oeuvre |
FR2885523A1 (fr) * | 2005-05-10 | 2006-11-17 | Seppic Sa | Composition synergique comprenant au moins trois polymeres d'origine synthetique et un glycol et utilisation de ladite composition comme agent tenseur dans les applications cosmetiques et dermopharceutiques |
WO2007057451A1 (fr) | 2005-11-21 | 2007-05-24 | L'oréal | Utilisation cosmetique d'agents tenseurs pour ameliorer l'epaisseur de la peau et/ou l'eclat du teint |
WO2007057448A1 (fr) | 2005-11-21 | 2007-05-24 | L'oréal | Compositions topiques favorisant l’homeostasie cutanee |
US7652100B2 (en) | 2001-01-15 | 2010-01-26 | L'oreal | Dispersions stabilized at temperatures of from 4 to 50 degrees celsius by means of a polymer comprising water-soluble units and units with an LCST |
WO2012130690A2 (fr) | 2011-03-31 | 2012-10-04 | L'oreal | Procédé de traitement de la transpiration humaine à l'aide d'un polymère filmogène hydrophobe tenseur, et compositions correspondantes |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2783417B1 (fr) * | 1998-09-17 | 2002-06-28 | Oreal | Compositions topiques cosmetiques ou dermatologiques comprenant des polyesters dendritiques |
FR2783418B1 (fr) * | 1998-09-17 | 2000-11-10 | Oreal | Composition anti-rides comprenant une association de polymeres tenseurs d'origine synthetique et/ou naturelle et de polyesters dendritiques |
FR2786674B1 (fr) | 1998-12-03 | 2001-01-05 | Oreal | Organe d'application pour l'application d'un produit sur la peau et ensemble ainsi equipe |
US7309688B2 (en) * | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US20030206958A1 (en) * | 2000-12-22 | 2003-11-06 | Cattaneo Maurizio V. | Chitosan biopolymer for the topical delivery of active agents |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
FR2819397B1 (fr) * | 2001-01-15 | 2003-03-07 | Oreal | Compositions a effet optique, notamment cosmetiques |
US20030059450A1 (en) * | 2001-09-24 | 2003-03-27 | Maibach Howard I. | Method and topical formulation for treating skin conditions associated with aging |
FR2830776A1 (fr) * | 2001-10-16 | 2003-04-18 | Oreal | Nanocapsules a base de polyesters sulfoniques hydrodispersibles colores |
DE10158199A1 (de) * | 2001-11-27 | 2003-06-18 | Beiersdorf Ag | Juckreizstillende kosmetische und dermatologische Zubereitungen |
FR2829025A1 (fr) * | 2002-03-21 | 2003-03-07 | Oreal | Utilisation de microgels de polysaccharides, en tant qu'agents tenseurs de la peau, dans des compositions cosmetiques |
US20030215476A1 (en) * | 2002-04-12 | 2003-11-20 | L'oreal | Multiple emulsion containing a tensioning agent |
US7041278B2 (en) * | 2002-07-31 | 2006-05-09 | Coty Inc | Cosmetic compositions with improved thermal stability and wear |
WO2004028494A2 (fr) | 2002-09-26 | 2004-04-08 | L'oreal | Composition de vernis à ongles comprenant un polymère séquencé |
MXPA03008714A (es) | 2002-09-26 | 2004-09-10 | Oreal | Polimeros secuenciados y composiciones cosmeticas que comprenden tales polimeros. |
AU2003301672A1 (en) * | 2002-10-21 | 2004-05-13 | Allegiance Corporation | Coating composition for skin-contacting surface of elastomeric articles and articles containing the same |
FR2860143B1 (fr) | 2003-09-26 | 2008-06-27 | Oreal | Composition cosmetique comprenant un polymere sequence et une huile siliconee non volatile |
FR2860156B1 (fr) * | 2003-09-26 | 2007-11-02 | Oreal | Composition cosmetique comprenant un agent tenseur et un polymere ethylenique sequence particulier |
FR2867681A1 (fr) * | 2004-03-19 | 2005-09-23 | Oreal | Composition cosmetique comprenant un agent tenseur et une dispersion de particules solides d'un polymere ethylenique greffe |
FR2863494A1 (fr) * | 2004-03-19 | 2005-06-17 | Oreal | Utilisation cosmetique d'une dispersion de particules solides d'un polymere ethylenique greffe dans une phase grasse liquide en tant qu'agent tenseur de la peau dans une composition cosmetique |
US8728451B2 (en) | 2004-03-25 | 2014-05-20 | L'oreal | Styling composition comprising, in a predominantly aqueous medium, a pseudo-block polymer, processes employing same and uses thereof |
US9308397B2 (en) * | 2004-04-30 | 2016-04-12 | The Procter & Gamble Company | Long-wearing cosmetic compositions |
US8318187B2 (en) * | 2004-04-30 | 2012-11-27 | The Procter & Gamble Company | Long-wearing cosmetic compositions with improved shine |
US20060141046A1 (en) * | 2004-05-06 | 2006-06-29 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
AU2005240189A1 (en) * | 2004-05-06 | 2005-11-17 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
FR2878438B1 (fr) * | 2004-11-26 | 2009-07-03 | Oreal | Composition cosmetique comprenant un agent tenseur et une hydroxyalkyl uree |
US20060193814A1 (en) * | 2005-02-25 | 2006-08-31 | Eduardo Ruvolo | Compositions for the treatment of signs of aging |
US20060193818A1 (en) * | 2005-02-25 | 2006-08-31 | Southall Michael D | Compositions containing amines and use thereof |
US20060193777A1 (en) * | 2005-02-25 | 2006-08-31 | Southall Michael D | Method of screening compounds for potential efficacy for the treatment of signs of aging |
US8278359B2 (en) * | 2005-02-25 | 2012-10-02 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin |
US8221046B2 (en) * | 2005-02-25 | 2012-07-17 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing amines and use thereof |
US8157467B2 (en) * | 2005-03-21 | 2012-04-17 | Johnson & Johnson Consumer Companies, Inc. | Device for administering fluid compositions including tensioning polymers |
US8153613B2 (en) * | 2006-05-24 | 2012-04-10 | Delaval Holding Ab | Barrier film-forming germicidal composition for controlling mastitis |
US7871634B2 (en) * | 2005-08-11 | 2011-01-18 | L'oréal | Cosmetic compositions useful for lengthening lashes |
US7547434B2 (en) * | 2005-09-09 | 2009-06-16 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for mitigating skin irritation |
WO2007042679A2 (fr) * | 2005-10-14 | 2007-04-19 | L'oreal | Composition cosmetique contenant un compose non phosphate a base d'adenosine et un polymere tenseur |
US20070092473A1 (en) * | 2005-10-21 | 2007-04-26 | L'oreal | Cosmetic composition containing a statistical polymer with a linear main chain of ethylenic nature |
BRPI0504797B1 (pt) * | 2005-10-27 | 2020-02-04 | Pele Nova Biotecnologia S A | formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação |
FR2897775B1 (fr) * | 2006-02-24 | 2013-05-03 | Elisabeth Laugier | Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations |
CN103432017B (zh) * | 2006-05-11 | 2016-05-18 | 气体产品与化学公司 | 含有官能化聚合物的个人护理组合物 |
KR100849019B1 (ko) * | 2006-06-28 | 2008-07-29 | (주)더페이스샵코리아 | 화이트 루핀 추출물을 함유하는 화장료 조성물 |
FR2904320B1 (fr) | 2006-07-27 | 2008-09-05 | Oreal | Polymeres sequences, et leur procede de preparation |
US7776840B2 (en) * | 2007-02-21 | 2010-08-17 | Cutanea Life Sciences, Inc. | Methods of use of biomaterial and injectable implant containing biomaterial |
US9233063B2 (en) * | 2009-12-17 | 2016-01-12 | Air Products And Chemicals, Inc. | Polymeric compositions for personal care products |
BR112012026019A2 (pt) * | 2010-04-12 | 2017-10-17 | Elc Man Llc | estimulação bioquímica de síntese de colágeno em células de pele e redução da aparência de linhas finas e rugas na pele |
WO2015111034A1 (fr) * | 2014-01-23 | 2015-07-30 | Noah Amit | Appareil et procédés de traitement de la peau, d'application d'un médicament et de formulation d'une crème |
FR3076218B1 (fr) | 2017-12-28 | 2019-12-27 | L'oreal | Composition gelifiee comprenant une microdispersion aqueuse de cire(s) |
GB201811312D0 (en) | 2018-07-10 | 2018-08-29 | Nuchido Ltd | Compositions |
WO2021219376A1 (fr) | 2020-04-28 | 2021-11-04 | Unilever Ip Holdings B.V. | Compositions de soins personnels avec des agents actifs à solubilité améliorée |
KR102295566B1 (ko) * | 2020-10-26 | 2021-08-31 | 한국에너지기술연구원 | 이젝터와 멤브레인을 이용한 냉방 시스템 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3463862A (en) * | 1964-05-21 | 1969-08-26 | Geneva Carol Mazza | Albumin containing comsmetic lotion |
US3471624A (en) * | 1966-11-08 | 1969-10-07 | Elizabeth Y Youngblood | Method of preparing a cosmetic formulation useful as a facial mask |
WO1996019180A1 (fr) * | 1994-12-20 | 1996-06-27 | Maybelline Intermediate Co. | Composition de maquillage revitalisante |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3463852A (en) * | 1966-01-14 | 1969-08-26 | Schering Corp | Treating allergies with steroids of the pregnane series |
US4360537A (en) * | 1976-05-03 | 1982-11-23 | International Telephone And Telegraph Corporation | Lipoprotein emulsions for food use and methods for preparing the same |
FR2435029A1 (fr) | 1978-08-31 | 1980-03-28 | Oreal | Procede pour mesurer au moins une caracteristique mecanique d'un materiau elastique et appareil correspondant |
US5100658A (en) * | 1989-08-07 | 1992-03-31 | The Procter & Gamble Company | Vehicle systems for use in cosmetic compositions |
US5443855B1 (en) * | 1991-09-18 | 1998-02-10 | Revlon Consumer Prod Corp | Cosmetics and pharmaceuticals containing extensins and related methods |
EP0614353A1 (fr) * | 1991-11-25 | 1994-09-14 | Richardson-Vicks, Inc. | Composition anti-rides et/ou pour la lutte contre l'atrophie de la peau |
FR2711059B1 (fr) * | 1993-10-15 | 1996-02-02 | Oreal | Composition cosmétique sous forme de vernis à ongles aqueux, coloré ou incolore, contenant en tant que substance filmogène des particules de polyester-polyuréthanne anionique à l'état dispersé. |
WO1996017582A1 (fr) * | 1994-12-05 | 1996-06-13 | Permethyl Specialties L.L.C. | Matieres polymeres hydrosolubles biodegradables destinees a des applications de soins cutanes, capillaires et cosmetiques |
AU2462697A (en) * | 1996-04-19 | 1997-11-12 | Hydron Technologies, Inc. | Skin tightening formulation and method of treating skin |
FR2758083B1 (fr) | 1997-01-03 | 1999-02-05 | Oreal | Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur |
-
1997
- 1997-01-03 FR FR9700033A patent/FR2758083B1/fr not_active Expired - Fee Related
- 1997-12-30 AU AU57701/98A patent/AU5770198A/en not_active Abandoned
- 1997-12-30 WO PCT/FR1997/002461 patent/WO1998029091A1/fr not_active Application Discontinuation
- 1997-12-30 EP EP97953978A patent/EP0912165A1/fr not_active Withdrawn
- 1997-12-30 US US09/142,046 patent/US6001367A/en not_active Expired - Fee Related
- 1997-12-30 JP JP10529720A patent/JPH11506474A/ja active Pending
-
1999
- 1999-07-07 US US09/348,167 patent/US6413526B1/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3463862A (en) * | 1964-05-21 | 1969-08-26 | Geneva Carol Mazza | Albumin containing comsmetic lotion |
US3471624A (en) * | 1966-11-08 | 1969-10-07 | Elizabeth Y Youngblood | Method of preparing a cosmetic formulation useful as a facial mask |
WO1996019180A1 (fr) * | 1994-12-20 | 1996-06-27 | Maybelline Intermediate Co. | Composition de maquillage revitalisante |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6413526B1 (en) | 1997-01-03 | 2002-07-02 | L'oreal | Cosmetic and/or dermatological composition comprising a dispersion of a polymer system, and use of this system as a tensioning agent |
JP2002539144A (ja) * | 1999-03-12 | 2002-11-19 | バイオテク エイエスエイ | 化粧品調合物 |
US7883692B2 (en) | 2000-07-21 | 2011-02-08 | L'oreal | Polymer comprising water soluble units and LCST units, and aqueous composition comprising same |
US7722859B2 (en) | 2000-07-21 | 2010-05-25 | L'oreal | Polymer comprising water-soluble units and LCST units, and aqueous composition comprising it |
US7115255B2 (en) | 2000-07-21 | 2006-10-03 | L'oreal | Polymer comprising water-soluble units and LCST units, and aqueous composition comprising same |
US7652100B2 (en) | 2001-01-15 | 2010-01-26 | L'oreal | Dispersions stabilized at temperatures of from 4 to 50 degrees celsius by means of a polymer comprising water-soluble units and units with an LCST |
EP1352626A1 (fr) * | 2002-04-12 | 2003-10-15 | L'oreal | Composition cosmétique sous forme d'émulsion multiple comprenant un agent tenseur |
FR2838343A1 (fr) * | 2002-04-12 | 2003-10-17 | Oreal | Composition cosmetique sous forme d'emulsion multiple comprenant un agent tenseur |
FR2846884A1 (fr) * | 2002-11-12 | 2004-05-14 | Oreal | Composition, notamment cosmetique, comprenant un latex tenseur et un polymere amphiphile ionique |
EP1419763A1 (fr) * | 2002-11-12 | 2004-05-19 | L'oreal | Composition cosmétique comprenant un latex tenseur et un polymère amphiphile ionique |
EP1708677A2 (fr) * | 2004-01-07 | 2006-10-11 | E-L Management Corp. | Composition cosmetique contenant une proteine et un inhibiteur d'enzyme |
EP1708677A4 (fr) * | 2004-01-07 | 2010-12-22 | E L Management Corp | Composition cosmetique contenant une proteine et un inhibiteur d'enzyme |
US7964582B2 (en) | 2005-03-21 | 2011-06-21 | J&J Consumer Companies, Inc. | Methods of treating skin and mucosal tissue atrophy using compositions including tensioning polymers |
WO2006102447A2 (fr) * | 2005-03-21 | 2006-09-28 | Johnson & Johnson Consumer Companies, Inc. | Methodes de traitement d'une atrophie des tissus cutanes et muqueux a l'aide de compositions renfermant des polymeres de tension |
WO2006102447A3 (fr) * | 2005-03-21 | 2007-03-22 | Johnson & Johnson Consumer | Methodes de traitement d'une atrophie des tissus cutanes et muqueux a l'aide de compositions renfermant des polymeres de tension |
WO2006102220A3 (fr) * | 2005-03-21 | 2007-04-19 | Johnson & Johnson Consumer | Compositions pour la peau comprenant des polymeres de mise en tension et utilisations |
WO2006102220A2 (fr) * | 2005-03-21 | 2006-09-28 | Johnson & Johnson Consumer Companies, Inc. | Compositions pour la peau comprenant des polymeres de mise en tension et utilisations |
FR2885037A1 (fr) * | 2005-05-02 | 2006-11-03 | Oreal | Kit de maquillage des matieres keratiniques et procede de mise en oeuvre |
FR2885038A1 (fr) * | 2005-05-02 | 2006-11-03 | Oreal | Kit de maquillage des matieres keratiniques et procede de mise en oeuvre |
FR2885523A1 (fr) * | 2005-05-10 | 2006-11-17 | Seppic Sa | Composition synergique comprenant au moins trois polymeres d'origine synthetique et un glycol et utilisation de ladite composition comme agent tenseur dans les applications cosmetiques et dermopharceutiques |
WO2007057448A1 (fr) | 2005-11-21 | 2007-05-24 | L'oréal | Compositions topiques favorisant l’homeostasie cutanee |
WO2007057451A1 (fr) | 2005-11-21 | 2007-05-24 | L'oréal | Utilisation cosmetique d'agents tenseurs pour ameliorer l'epaisseur de la peau et/ou l'eclat du teint |
WO2012130690A2 (fr) | 2011-03-31 | 2012-10-04 | L'oreal | Procédé de traitement de la transpiration humaine à l'aide d'un polymère filmogène hydrophobe tenseur, et compositions correspondantes |
Also Published As
Publication number | Publication date |
---|---|
FR2758083B1 (fr) | 1999-02-05 |
AU5770198A (en) | 1998-07-31 |
JPH11506474A (ja) | 1999-06-08 |
EP0912165A1 (fr) | 1999-05-06 |
US6001367A (en) | 1999-12-14 |
FR2758083A1 (fr) | 1998-07-10 |
US6413526B1 (en) | 2002-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998029091A1 (fr) | Composition cosmetique et/ou dermatologique contenant une dispersion d'un systeme polymerique et utilisation de ce systeme comme tenseur | |
WO1998029092A1 (fr) | Composition cosmetique et/ou dermatologique contenant une dispersion aqueuse d'un systeme polymerique et utilisation de ce systeme comme tenseur | |
EP0987016B1 (fr) | Composition anti-rides comprenant une association de polymères tenseurs d'origine synthétique et/ou naturelle et de polymères dendritiques | |
EP0755673B1 (fr) | Composition stable contenant un actif cosmétique et/ou dermatologique sensible à l'eau | |
CA2147089C (fr) | Composition cosmetique et/ou dermatologique contenant un tri(alpha-hydroxyacylate) de glycerol comme seul precurseur de glycerol | |
WO2009101503A2 (fr) | Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques | |
EP1656970A1 (fr) | Composition cosmétique comprenant un hydrolysat de protéines de riz et un agent augmentant la synthèse des glycosaminoglycanes | |
FR2799370A1 (fr) | Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement | |
FR2877220A1 (fr) | Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane | |
WO2002047650A1 (fr) | Utilisation d'au moins une sapogenine pour prevenir les signes du viellissement cutane | |
FR2838343A1 (fr) | Composition cosmetique sous forme d'emulsion multiple comprenant un agent tenseur | |
EP1481677B1 (fr) | Composition cosmétique et/ou dermatologique contenant l'acide ascorbique stabilisé par au moins un polymère amphiphile choisi parmi les oligomères ou polymères dérivés de polyisobutylène | |
EP1479367A1 (fr) | Utilisation d'un extrait de bactérie filamenteuse non photosynthéthique non fructifiante pour le renforcement des matières kératiniques | |
EP0755676B1 (fr) | Utilisation d'acides monocarboxyliques pour le traitement des matières kératiniques | |
FR2847816A1 (fr) | Composition comprenant un pseudodipeptide et un agent augmentant la synthese d'elastine | |
EP1303252A1 (fr) | Composition comprenant un precurseur de ceramides, utilisation pour ameliorer l'epiderme naturel ou reconstruit, equivalent de peau obtenu | |
EP0973495B1 (fr) | Utilisation d'extrait(s) de graines de pois bambara dans une composition cosmetique | |
FR2832926A1 (fr) | Composition cosmetique ou dermatologique comprenant un retinoide et/ou un carotenoide et l'acide acexamique | |
EP1703889B1 (fr) | Utilisation cosmetique ou pharmaceutique d'un extrait de liege hydrolyse | |
FR3116728A1 (fr) | Eau végétale de riz de Camargue et utilisations notamment en cosmétique | |
FR2940114A1 (fr) | Kit de revetement des matieres keratiniques comprenant une proteine et un agent de reticulation chimique ou de complexation ionique | |
FR2828400A1 (fr) | Composition cosmetique ou dermatologique comprenant une association entre de l'igf1 et/ou un compose mimetique de l'igf1, et au moins un retinoide et/ou au moins un derive de retinoide | |
WO2003059314A1 (fr) | Utilisation de l'acide methyl glycinediacetique ou de ses derives comme desquamant | |
FR2844200A1 (fr) | Utilisation cosmetique ou pharmaceutique d'un hydrolysat dephenolise de proteines de tournesol | |
CH706322A2 (fr) | Utilisation d'agonistes des récepteurs opioïdes delta dans le domaine de la cosmétique et de la dermocosmétique. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997953978 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 529720 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09142046 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997953978 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997953978 Country of ref document: EP |